Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability

PaperCitations, authors & open-access status

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 73 citations, 2024 year and hybrid oa status.

73
Citations
2024
Year
hybrid
OA Status

Related on ScholarIQ

Alise Carlson
Author
Drugs
Journal
Monoclonal and Polyclonal Antibodies Research
Topic
Monoclonal and Polyclonal Antibodies Research
Topic
CAR-T cell therapy research
Topic
Immunotherapy and Immune Responses
Topic
470M+ articles · free account